TSCA evaluation decision for Premanufacture Number (PMN) P-16-0326 under Section 5(a)(3)(C)
The Environmental Protection Agency (EPA) has released a TSCA Section 5(a)(3)(C) determination for Premanufacture Number (PMN) P-16-0326. This determination, published in June 2020, is a public document and can be accessed online.
The TSCA Section 5(a)(3)(C) refers to the requirements under which the EPA evaluates PMNs for new chemical substances before they can be manufactured or imported. The evaluation typically addresses whether the chemical poses an unreasonable risk or if it can be manufactured with certain restrictions.
The determination for PMN P-16-0326 does not contain Confidential Business Information (CBI) and is a review determination by the EPA under the amended TSCA. The document, released as a PDF document, provides an evaluation of the safety of the chemical substance or mixture and may include recommendations for further testing or risk management measures.
It's important to note that the search results do not contain specific information on the TSCA Section 5(a)(3)(C) determination for PMN P-16-0326. Therefore, if you wish to access the official determination, you may need to consult the EPA’s official TSCA Chemical Substance Inventory or PMN status database, or request information directly from EPA’s Office of Chemical Safety and Pollution Prevention.
The TSCA Section 5(a)(3)(C) Determination for PMN P-16-0326 is one of multiple similar determinations made by the EPA under the amended TSCA, demonstrating the agency's ongoing efforts to ensure the safety of new chemical substances.
In conclusion, the EPA's TSCA Section 5(a)(3)(C) determination for PMN P-16-0326 is an important document for those interested in the safety and regulation of new chemical substances. The document can be accessed online and provides valuable insights into the EPA's evaluation of this specific chemical substance or mixture.
The TSCA Section 5(a)(3)(C) determination for PMN P-16-0326, released by the Environmental Protection Agency (EPA), offers invaluable information about the health-and-wellness implications of new chemical substances, as it evaluates whether they pose unreasonable risks. This determination, focused on medical-conditions and environmental-science, is a crucial resource for those interested in the safety of new chemical substances.
%20P-16-0326%20under%20Section%205(a)(3)(C)){kind=link}